Management of hypertension in CKD

2004, K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease, Am J Kidney Dis, 43, 1 Mailloux, 1998, Hypertension in patients with chronic renal disease, Am J Kidney Dis, 32, 120, 10.1053/ajkd.1998.v32.pm9820471 Agarwal, 2009, Blood pressure components and the risk for end stage renal disease and death in chronic kidney disease, Clin J Am Soc Nephrol, 4, 830, 10.2215/CJN.06201208 Agarwal, 2005, Correlates of systolic hypertension in patients with chronic kidney disease, Hypertension, 46, 514, 10.1161/01.HYP.0000178102.85718.66 Guyton, 1980, Salt balance and long-term blood pressure control, Annu Rev Med, 31, 15, 10.1146/annurev.me.31.020180.000311 Guyton, 1984, The pathogenic role of the kidney, J Cardiovasc Pharmacol, 6, 151, 10.1097/00005344-198400061-00025 2012, KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease, Kidney Int, 337 Mishra, 2005, Does dietary salt increase the risk for progression of kidney disease?, Curr Hypertens Rep, 7, 385, 10.1007/s11906-005-0076-2 Jones-Burton, 2006, An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease, Am J Nephrol, 26, 268, 10.1159/000093833 Ying, 1999, Dietary salt increases endothelial nitric oxide synthase and TGF-β 1 in rat aortic endothelium, Am J Physiol, 277, 1293 Sacks, 2001, Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet, N Engl J Med, 344, 3, 10.1056/NEJM200101043440101 Chagnac, 2008, Obesity induced glomerular hyperfiltration: Its involvement in the pathogenesis of tubular sodium reabsorption, Nephrol Dial Transpl, 23, 3946, 10.1093/ndt/gfn379 Lee, 2006, Serum uric acid is associated with microalbuminuria in prehypertension, Hypertension, 47, 962, 10.1161/01.HYP.0000210550.97398.c2 Bulpitt, 1975, Serum uric acid in hypertensive patients, Br Heart J, 37, 1210, 10.1136/hrt.37.12.1210 Krug, 2008, Aldosterone and metabolic syndrome: Is increased aldosterone in metabolic syndrome patients an additional risk factor?, Hypertension, 51, 1252, 10.1161/HYPERTENSIONAHA.107.109439 James PA, Oparil S, Carter BL, et al. 2014 evidence based guideline for the management of high blood pressure in adults. http://jama.jamanetwork.com Accessed 18.12.13. Hansson, 1998, Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group, Lancet, 351, 1755, 10.1016/S0140-6736(98)04311-6 1998, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group, BMJ, 317, 703, 10.1136/bmj.317.7160.703 Peterson, 1995, Blood pressure control, proteinuria and the progression of renal disease. The Modification of Diet in Renal Disease Study, Ann Intern Med, 123, 754, 10.7326/0003-4819-123-10-199511150-00003 Coresh, 2001, Prevalence of high blood pressure and elevated serum creatinine level in United States: findings from the third National Health and Nutrition Examination Survey (1988–1994), Arch Intern Med, 161, 1207, 10.1001/archinte.161.9.1207 2002, Major outcomes in high risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), JAMA, 288, 2981, 10.1001/jama.288.23.2981 Jafar, 2003, Progression of chronic kidney disease: the role of blood pressure control, proteinuria and angiotensin converting enzyme inhibition. A patient level meta-analysis, Ann Intern Med, 139, 244, 10.7326/0003-4819-139-4-200308190-00006 Mann, 2008, Renal outcomes with telmisartan, ramipril or both in people with high vascular risk (ONTARGET study): a multicentre, randomized, double blind, controlled trial, Lancet, 372, 547, 10.1016/S0140-6736(08)61236-2 Schmeider, 2007, The potential role of prorenin in diabetic nephropathy, J Hypertens, 25, 1323, 10.1097/HJH.0b013e328048d01c Esler, 2012, Renal sympathetic denervation for treatment of drug resistant hypertension, Circulation, 126, 2976, 10.1161/CIRCULATIONAHA.112.130880